Hundreds of CEOs from the healthcare, biotech and pharmaceutical industries plan to huddle next month with investment professionals to seek new business models to bridge healthcare’s gap between innovation and financial resources. They will be meeting at the 2nd Annual Global Leaders Healthcare Forum, in San Francisco on January 10, 2012. The forum is hosted by The Global Leaders, an exclusive business network of 2 million CEOs and other senior executives worldwide.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53879-the-global-leaders-healthcare-forum-san-francisco-2011
Marriott Hotels & Resorts, the signature brand of Marriott International (NYSE:MAR), renowned for its expertise in hosting meetings, is “re-imagining” the traditional small meeting to become a collaborative work experience that will promote creativity and innovation. Inspired by the work styles of Gen X and Gen Y, Marriott Hotels & Resorts has exclusively partnered with Steelcase, the leader in workspace design, and launched today Workspring at Marriott. Redmond Marriott Town Center, near Seattle, is the first hotel to offer the small meetings suite.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58273-marriott-hotels-resorts-workspring-at-marriott-small-meetings-suite
At its annual meeting of more than 10,000 financial representatives and staff members today, Northwestern Mutual announced its new multi-year philanthropic program to fight childhood cancer. The effort, through the Northwestern Mutual Foundation, builds upon the company’s legacy of helping children and families. It leverages Northwestern Mutual’s field force throughout the country to implement a range of community events and programs to raise awareness and money for pediatric cancer.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53645-northwestern-mutual-philanthropic-campaign-pediatric-cancer-research
Upsher-Smith Laboratories, Inc. [http://www.upsher-smith.com] today announced that its epilepsy-focused educational website, http://www.Epilog.us, has been expanded to include thought-leader commentary on issues related to Epilepsy and Comorbidities. The newly updated website will make its debut at the 64th Annual American Academy of Neurology Meeting in New Orleans on April 23 – 26, 2012, at the Upsher-Smith exhibit, booth number 128.
TO view Multimedia News Release, go to http://www.multivu.com/mnr/55934-upsher-smith-expands-epilog-us-on-epilepsy-comorbidities
Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that data from two Phase 2 trials with SAR236553/REGN727, an investigational, high-affinity, subcutaneously administered, fully-human antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), were presented at the American College of Cardiology’s (ACC) 61st Annual Scientific Meeting in Chicago.
The data showed that treatment with SAR236553/REGN727 over 8 to 12 weeks significantly reduced mean low-density lipoprotein-cholesterol (LDL-C, or “bad” cholesterol) by 40% to 72% in patients with elevated LDL-C on stable dose of statins.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55299-sanofi-regeneron-pharmaceuticals-lipid-lowering-medications-pcsk9-antibody
Kate Hudson, Kay Krill, ANN INC.‘s President and CEO, and Monica Mishra, one of the 2012 ANNpower Fellows and 2013 Project Grant Winner were in New York City to speak at the Clinton Global initiative 2013 Annual Meeting. They spoke at one of the commitment sessions called LESSONS FROM THE FRONT LINES OF WOMEN’S LEADERSHIP specifically on:
Shell today announced that it will go ahead with the first carbon capture and storage (CCS) project for an oil sands operation in Canada. The Quest project will be built on behalf of the Athabasca Oil Sands Project joint venture owners (Shell, Chevron and Marathon Oil) and with support from the Governments of Canada and Alberta.
CCS is critical to meeting the huge projected increase in global energy demand while reducing carbon dioxide (CO2) emissions, explained Peter Voser, Chief Executive Officer of Royal Dutch Shell plc. “If you want to achieve climate change goals, CCS has to be part of the solution. We are helping to advance CCS technology on a number of fronts around the world, but Quest will be our flagship project.”
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/shell-first-oil-sands-css-project/56586/
Some of us process sensory input more effectively through visual means, others through auditory stimuli, and others through a kinesthetic (a touch or feel) approach. Here\\\'s a very simple way to begin to contemplate which way your genius accesses information. Imagine for a moment that you are buying a new item of clothing for an important meeting. Would you be most influenced to buy primarily for a) the color and style of the outfit; b) the benefits the salesperson tells you about the clothing; c) the texture and feel of the fabric. If you chose \\\
CHS Inc., the nation’s leading cooperative and a global energy, grains and foods company, is committed to continued growth that will drive economic value to its farmer owners and the rural communities in which they live, its leaders told attendees at its recent annual meeting.
“Our ultimate responsibility is to invent the CHS of the future by making the decisions, executing the investments and managing the financial health of this company in a manner that not only adds value for you today, but continues to pay off 10 and 20 years down the road,” CHS President and Chief Executive Officer Carl Casale told attendees. “Ultimately, it’s about taking actions today that will benefit tomorrow’s owner, the generations that are now playing in farm yards or buying their first blue FFA jackets.”
To view the Multimedia News Release, go to http://www.multivu.com/mnr/58034-chs-inc-putting-future-first-for-cooperative-farmer-owners
Two all-electric vehicles fall short of meeting the Insurance Institute for Highway Safety’s awards criteria, but consumers who want to minimize gas consumption while also prioritizing safety can choose from two plug-in hybrids that earn the 2017 TOP SAFETY PICK+ award.
The two recently evaluated all-electric models are the 2017 Tesla Model S and the 2017 BMW i3. The plug-in hybrid models are the Chevrolet Volt, whose award was announced in December, and the Toyota Prius Prime.
To qualify for the 2017 TOP SAFETY PICK award, a vehicle must earn good ratings in all five crashworthiness evaluations — small overlap front, moderate overlap front, side, roof strength and head restraints — and come with a front crash prevention system that earns an advanced or superior rating. The “plus” is awarded to vehicles that meet all those criteria and also come with good or acceptable headlights.
Asuragen Inc., a leading molecular diagnostics company, today announced results from a study demonstrating that a new molecular test called Xpansion Interpreter® can improve the determination of a woman’s risk of having a child with fragile X syndrome, the most common inherited cause of intellectual disability and autism, compared to existing risk measures. The Xpansion Interpreter Test is based on a technology breakthrough that reveals both the number and position of “interrupting” DNA sequences in the fragile X gene of the mother and more accurately estimates the likelihood that her child will have fragile X syndrome. The study will be published in the April issue of the American Journal of Medical Genetics and presented today at the 2013 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting in Phoenix, AZ.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60719-asuragen-xpansion-interpreter-xi-test-data-fragile-x-syndrome-autism
